This may be because CXCR3 activation of the PLC-β/Ca2+ signaling pathway reduces the inward flow of intracellular calcium ions, decreases the adhesion of cells to the substrate through the activation of μ-calpain, and contributes to tumor cell migration. The gene discussed is CXCR3; the disease is neoplasm.